{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:19:14Z","timestamp":1780636754822,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.06.005","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T07:15:25Z","timestamp":1561792525000},"page":"7011-7018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1349-2310","authenticated-orcid":false,"given":"Juliana","family":"Coronel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"B\u00fcrgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Anderlei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Sandig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-5943","authenticated-orcid":false,"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.005_b0005","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.biotechadv.2018.04.011","article-title":"Perfusion mammalian cell culture for recombinant protein manufacturing \u2013 A critical review","volume":"36","author":"Bielser","year":"2018","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2019.06.005_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.24608","article-title":"Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty","volume":"110","author":"Pollock","year":"2013","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.005_b0015","doi-asserted-by":"crossref","unstructured":"Castilho LR. Continuous animal cell perfusion processes: the first step toward integrated continuous biomanufacturing. In: Ganapathy Subramanian, editor. Contin. Process. Pharm. Manuf., Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2014, p. 115\u201354. doi: http:\/\/doi.org\/10.1002\/9783527673681.ch06.","DOI":"10.1002\/9783527673681.ch06"},{"key":"10.1016\/j.vaccine.2019.06.005_b0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","article-title":"Bioreactor concepts for cell culture-based viral vaccine production","volume":"14","author":"Gallo-Ram\u00edrez","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.06.005_b0025","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/biot.201400388","article-title":"Designing cell lines for viral vaccine production: where do we stand?","volume":"10","author":"Genzel","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2019.06.005_b0030","first-page":"33","article-title":"Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1000-liter scale","volume":"115","author":"Zhang","year":"2009","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0035","doi-asserted-by":"crossref","unstructured":"Gupta SK. Upstream continuous process development. In: Subramanian G, editor. Contin. Biomanufacturing - Innov. Technol. Methods, Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2017, p. 201\u201332. doi: http:\/\/doi.org\/10.1002\/9783527699902.ch8.","DOI":"10.1002\/9783527699902.ch8"},{"key":"10.1016\/j.vaccine.2019.06.005_b0040","doi-asserted-by":"crossref","unstructured":"P\u00f6rtner R. Bioreactors for Mammalian Cells. In: Al-Rubeai M, editor. Anim. Cell Cult. Cell Eng. vol 9., Springer, Cham; 2015, p. 89\u2013135. doi: http:\/\/doi.org\/10.1007\/978-3-319-10320-4_4.","DOI":"10.1007\/978-3-319-10320-4_4"},{"key":"10.1016\/j.vaccine.2019.06.005_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10616-006-9005-8","article-title":"Reactor engineering in large scale animal cell culture","volume":"50","author":"Nienow","year":"2006","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2019.06.005_b0050","first-page":"45","article-title":"Orbitally shaken single-use bioreactors","volume":"138","author":"Kl\u00f6ckner","year":"2014","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bej.2010.08.005","article-title":"Determination of a scale-up factor from mixing time studies in orbitally shaken bioreactors","volume":"52","author":"Tissot","year":"2010","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.vaccine.2019.06.005_b0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1008025016272","article-title":"Disposable bioreactor for cell culture using wave-induced agitation","volume":"30","author":"Singh","year":"1999","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2019.06.005_b0065","doi-asserted-by":"crossref","unstructured":"Galliher PM. Single use technology and equipment. In: G\u00fcnter Jagschies, Eva Lindskog, Karol \u0141\u0105cki, Parrish Galliher, editors. Biopharm. Process., Elsevier; 2018, p. 557\u201377. doi: http:\/\/doi.org\/10.1016\/B978-0-08-100623-8.00029-3.","DOI":"10.1016\/B978-0-08-100623-8.00029-3"},{"key":"10.1016\/j.vaccine.2019.06.005_b0070","article-title":"A novel seed-train process using high-density cell banking, a disposable bioreactor, and perfusion technologies","volume":"13","author":"Wright","year":"2015","journal-title":"Bioprocess Int"},{"key":"10.1016\/j.vaccine.2019.06.005_b0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/elsc.201300130","article-title":"Harmonization and characterization of different single-use bioreactors adopting a new sparger design","volume":"14","author":"Minow","year":"2014","journal-title":"Eng Life Sci"},{"key":"10.1016\/j.vaccine.2019.06.005_b0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/btpr.1704","article-title":"Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactorTM. Part I. Effect of the cell density on the process","volume":"29","author":"Clincke","year":"2013","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2019.06.005_b0085","first-page":"1","article-title":"Process intensification of EB66\u00ae cell cultivations leads to high-yield yellow fever and Zika virus production","author":"Nikolay","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0090","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2017.10.112","article-title":"High-cell-density cultivations to increase MVA virus production","volume":"36","author":"V\u00e1zquez-Ram\u00edrez","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.005_b0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/hgtb.2017.086","article-title":"Scalable lentiviral vector production using stable HEK293SF producer cell lines","volume":"28","author":"Manceur","year":"2017","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.vaccine.2019.06.005_b0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.vaccine.2013.11.044","article-title":"Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor","volume":"32","author":"Tapia","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.005_b0105","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","article-title":"Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production","volume":"100","author":"Tapia","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1472-6750-14-72","article-title":"The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis","volume":"14","author":"Lohr","year":"2014","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0115","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","article-title":"High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells","volume":"32","author":"Genzel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.005_b0120","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s00253-019-09694-2","article-title":"High titer MVA and influenza A virus production using a hybrid fed-batch\/perfusion strategy with an ATF system","volume":"103","author":"V\u00e1zquez-Ram\u00edrez","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0125","unstructured":"Lohr V. Characterization of the avian designer cells AGE1.CR and AGE1.CR.pIX considering growth, metabolism and production of influenza virus and Modified Vaccinia Virus Ankara (MVA). Otto von Guericke University Magdeburg, Magdeburg, Germany, 2014."},{"key":"10.1016\/j.vaccine.2019.06.005_b0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2007.10.002","article-title":"Monitoring influenza virus content in vaccine production: Precise assays for the quantitation of hemagglutination and neuraminidase activity","volume":"36","author":"Kalbfuss","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.06.005_b0135","doi-asserted-by":"crossref","unstructured":"Genzel Y, Reichl U. Vaccine production. In: P\u00f6rtner R, editor. Anim. Cell Biotechnol. Methods Protoc. 2nd ed., Humana Press; 2007, p. 457\u201373. doi: http:\/\/doi.org\/10.1007\/978-1-59745-399-8_21.","DOI":"10.1007\/978-1-59745-399-8_21"},{"key":"10.1016\/j.vaccine.2019.06.005_b0140","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2012.05.065","article-title":"Productivity, apoptosis, and infection dynamics of influenza A\/PR\/8 strains and A\/PR\/8-based reassortants","volume":"30","author":"Isken","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.005_b0145","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1007\/s00253-016-7542-4","article-title":"Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells","volume":"100","author":"Frensing","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0042-6822(62)90182-4","article-title":"Inhibition by ammonium ion of the growth of influenza virus in chorioallantoic tissue","volume":"18","author":"Eaton","year":"1962","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.06.005_b0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-1656(95)00196-4","article-title":"The importance of ammonia in mammalian cell culture","volume":"46","author":"Schneider","year":"1996","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D","article-title":"Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells","volume":"55","author":"Chuppa","year":"1997","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.005_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bej.2016.02.003","article-title":"Characterization and comparison of ATF and TFF in stirred bioreactors for continuous mammalian cell culture processes","volume":"110","author":"Karst","year":"2016","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.vaccine.2019.06.005_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00353919","article-title":"Engineering challenges in high density cell culture systems","volume":"22","author":"Ozturk","year":"1996","journal-title":"Cytotechnology"},{"key":"10.1016\/j.vaccine.2019.06.005_b0175","unstructured":"Adolf K\u00fchner AG, User Manual OrbShake Bioreactor SB10-X (# 52409 version 2), 2017."},{"key":"10.1016\/j.vaccine.2019.06.005_b0180","unstructured":"Centers for Disease Control and Prevention. Cell-Based Flu Vaccines | Seasonal Influenza (Flu) | CDC 2016. https:\/\/www.cdc.gov\/flu\/protect\/vaccine\/cell-based.htm (accessed September 27, 2018)."},{"key":"10.1016\/j.vaccine.2019.06.005_b0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bit.20074","article-title":"Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures","volume":"86","author":"Henry","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.005_b0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jbiotec.2017.01.020","article-title":"Shear contributions to cell culture performance and product recovery in ATF and TFF perfusion systems","volume":"246","author":"Wang","year":"2017","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6750-11-84","article-title":"Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture","volume":"11","author":"Petiot","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/vim.1999.12.175","article-title":"A fatal relationship\u2014influenza virus interactions with the host cell","volume":"12","author":"Ludwig","year":"1999","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/jvi.70.1.663-666.1996","article-title":"bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation","volume":"70","author":"Olsen","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.06.005_b0210","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2019.06.005_b0215","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2009.02.027","article-title":"Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production\u2014Flow cytometry and mathematical modeling","volume":"27","author":"Schulze-Horsel","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:59Z","timestamp":1759401359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19307649"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}